A742-Fall 2018-Quiz 2-v3

.pdf

School

University of Pennsylvania *

*We aren’t endorsed by this school

Course

242

Subject

Accounting

Date

Jan 9, 2024

Type

pdf

Pages

11

Uploaded by MateTeamTiger43

Report
Name ACCOUNTING 742 Quiz 2 Fall 2018 Instructions Please print or type your name in the space provided above Sign the HONOR CODE statement at the bottom of the page and return this page with your answers. You have 80 minutes to do this exam. This Quiz is open book and open notes. You are allowed to look up any accounting rules or business terms you don’t understand. However, you are not allowed to contact other people. Show your work to receive partial credit. If you feel you need to make an assumption to answer a question, state that assumption with your answer. Maximum Points Points Scored Question I -- Long Term Assets 29 Question II – Financial Securities and Misc 42 Question III – Income Taxes 38 TOTAL 109 The Wharton School Honor Code applies to this exam. In particular, you may not talk about the exam with other people. By signing below, you agree to abide by the Honor Code. Signature
2 Problem I (29 points) – Long Term Assets Refer to the excerpts from the Annual Report for Merck for the fiscal year ending December 31, 2017. Unless directed otherwise, if you need to assume a tax rate, use 30%. 1. (2 pts) How much was Merck’s R&D expense during 2017? 2. (2 pts) How much Goodwill did Merck add to their balance sheet as a result of their acquisition of Cubist? (note that this was NOT in 2017) 3. (2 pts) How much Goodwill amortization did Merck recognize in 2017? 4. (2 pts) How much Goodwill impairment charges did Merck recognize in 2017? 5. (2 pts) How much IPR&D does Merck have on its balance sheet at the end of 2017?
3 6. (4 pts) Why is there no amortization being recorded for IPR&D in any of the years in Merck’s financial statements? 7. (2 pts) How much IPR&D was completed in 2017 (give me a dollar value)? 8. (4 pts) Why does “Intangible Asset Impairment Charges” show up as a positive adjustment in the Operating section of the cash flow statement? 9. (2 pts) How much was Merck’s Depreciation Expense in 2017? ( I don’t what the total for Depreciation and Amortization, I just want the amount for Depreciation).
4 10. (7 pts) Suppose Merck was allowed to use Mark-to-Market (or Fair Value accounting) for its PP&E like you’re allowed to under IFRS. Suppose the Fair Value of Merck’s PPE was $25,000 at the end of 2017 and $20,000 at the end of 2016 (in millions, just as the numbers on the balance sheet and income statement are). Assume there are no asset dispositions (sales). a. How much higher or lower would Merck’s Pre-tax Income for 2017 have been relative to what they reported under US GAAP (ignore taxes)? (Give me a dollar amount and indicate if IFRS-compatible income would be higher or lower than US GAAP). b. How much higher or lower would Merck’s Other Comprehensive Income (OCI) for 2017 would have been relative to what they reported under US GAAP (also pre-tax)? (Again, give me a dollar amount and indicate if the IFRS compatible OCI would be higher or lower than under US GAAP)
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help